Literature DB >> 6491284

The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers.

R L Hunter, B Bennett.   

Abstract

We tested the ability of 17 surface-active agents to enhance antibody formation and inflammation. The surfactants were all block copolymers of hydrophilic polyoxyethylene (POE) and hydrophobic polyoxypropylene (POP), which differed in m.w. and mode of linkage of POP to POE. Mice were injected in each rear footpad with 1.25 mg of each surfactant with 25 micrograms of bovine serum albumin in an oil-in-water emulsion. Each agent produced a distinct pattern of immune response and inflammation. Preparations that are large and insoluble with the POE chains flanking the POP chains were very effective adjuvants for increasing antibody formation. They also activated complement and induced the release of chemotactic factors from serum. Increasing the percent of POE decreased adjuvant activity and inflammation. Decreasing the m.w. of the molecules while maintaining the proportions of POP and POE decreased the adjuvant activity and increased inflammation. Preparations synthesized in the reverse order, with the POP flanking POE, tended to induce granulomas instead of antibody. These data demonstrate that block copolymer surfactants have a spectrum of biologic activities that depend on the size and arrangement of their constituent parts. We suggest that much of the activity of these agents derives from their ability to form adsorptive surfaces similar to those of a mycobacterial glycolipid, quartz, and monosodium urate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491284

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Sterile filtration of a parenteral emulsion.

Authors:  D M Lidgate; T Trattner; R M Shultz; R Maskiewicz
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

2.  The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin.

Authors:  J M Brewer; J Alexander
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

3.  Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease.

Authors:  R Holmdahl; T J Goldschmidt; S Kleinau; C Kvick; R Jonsson
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

4.  Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.

Authors:  G J Zigterman; H Snippe; M Jansze; E B Ernste; M J De Reuver; J M Willers
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 5.  Photodynamic therapy: one step ahead with self-assembled nanoparticles.

Authors:  Pinar Avci; S Sibel Erdem; Michael R Hamblin
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

6.  Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.

Authors:  D M Lidgate; R C Fu; N E Byars; L C Foster; J S Fleitman
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

7.  A new bioerodible polymer insert for the controlled release of metronidazole.

Authors:  K A Gates; H Grad; P Birek; P I Lee
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

8.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.

Authors:  M F Powell; L C Foster; A R Becker; W Lee
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

9.  Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.

Authors:  G J Zigterman; K Schotanus; E B Ernste; G J Van Dam; M Jansze; H Snippe; J M Willers
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

10.  Block copolymers have differing adjuvant effects on the primary immune response elicited by genetic immunization and on further induced allergy.

Authors:  Karine Adel-Patient; Laetitia Pothelune; Sandrine Ah-Leung; Jean-Michel Wal; Christophe Créminon; Jean-Marc Chatel
Journal:  Clin Vaccine Immunol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.